Yipinhong Pharmaceutical Co Ltd Class A (300723) — Net Asset Quality Index
Yipinhong Pharmaceutical Co Ltd Class A (300723) has a Net Asset Quality Index of 42.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.70 Billion minus total liabilities of CN¥2.73 Billion yields net assets of CN¥1.97 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300723 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Yipinhong Pharmaceutical Co Ltd Class A Net Asset Quality Index Over Time (2013–2025)
This chart shows how Yipinhong Pharmaceutical Co Ltd Class A's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 42.0%, representing net assets of CN¥1.97 Billion against total assets of CN¥4.70 Billion CNY. Explore how efficiently does Yipinhong Pharmaceutical Co Ltd Class A generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Yipinhong Pharmaceutical Co Ltd Class A stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.8% | CN¥1.41 Billion | CN¥4.04 Billion | CN¥2.64 Billion | ▼ -9.2 pp |
| 2024 | 44.0% | CN¥1.94 Billion | CN¥4.40 Billion | CN¥2.47 Billion | ▼ -15.0 pp |
| 2023 | 59.0% | CN¥2.60 Billion | CN¥4.41 Billion | CN¥1.81 Billion | ▲ +6.1 pp |
| 2022 | 52.8% | CN¥2.17 Billion | CN¥4.10 Billion | CN¥1.93 Billion | ▼ -1.6 pp |
| 2021 | 54.5% | CN¥2.02 Billion | CN¥3.70 Billion | CN¥1.69 Billion | ▼ -15.2 pp |
| 2020 | 69.7% | CN¥1.50 Billion | CN¥2.15 Billion | CN¥650.14 Million | ▼ -5.0 pp |
| 2019 | 74.7% | CN¥1.34 Billion | CN¥1.79 Billion | CN¥454.20 Million | ▲ +1.7 pp |
| 2018 | 73.0% | CN¥1.30 Billion | CN¥1.78 Billion | CN¥481.67 Million | ▼ -1.8 pp |
| 2017 | 74.8% | CN¥1.11 Billion | CN¥1.48 Billion | CN¥373.45 Million | ▲ +30.1 pp |
| 2016 | 44.7% | CN¥336.50 Million | CN¥752.32 Million | CN¥415.82 Million | ▲ +12.9 pp |
| 2015 | 31.8% | CN¥200.66 Million | CN¥630.56 Million | CN¥429.90 Million | ▲ +14.4 pp |
| 2014 | 17.4% | CN¥127.52 Million | CN¥733.80 Million | CN¥606.28 Million | ▼ -27.8 pp |
| 2013 | 45.1% | CN¥185.61 Million | CN¥411.27 Million | CN¥225.66 Million | — |